Relmada Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
RLMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
2222 Ponce De Leon Blvd. 3 Rd Floor, Coral Gables, FL

Insiders trading volume in the past year

Relmada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sergio Traversa Chief Executive Officer, Director $2.8M +$952K +51.6% Nov 5, 2025
Maged Shenouda Chief Financial Officer $1.73M +$1.2M +223% Nov 5, 2025
Paul Kelly Chief Operating Officer, Director $1.11M +$284K +34.6% Nov 5, 2025
Chuck Ence CAO and COO $889K +$403K +82.8% Nov 5, 2025
Cedric O'Gorman Chief Medical Officer $32.2K May 23, 2023
Charles J. Casamento Director $0 Jun 26, 2025
Eric Schmidt Director May 25, 2023
Fabiana Fedeli Director Jun 26, 2025
John Glasspool Director Jun 26, 2025

Recent Insider Transactions by Companies or Individuals for Relmada Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.